Acura Pharmaceuticals Inc (ACUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -965 | -287 | -595 | -3,774 | -3,929 |
| Depreciation Amortization | 106 | 86 | 66 | 339 | 272 |
| Accounts receivable | -37 | 29 | 73 | -78 | -10 |
| Accounts payable and accrued liabilities | 47 | -96 | -129 | -368 | -275 |
| Other Working Capital | -475 | -579 | 199 | 121 | -158 |
| Other Operating Activity | 685 | 753 | 733 | 3,142 | 2,960 |
| Operating Cash Flow | $-639 | $-94 | $347 | $-618 | $-1,140 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 269 | 269 | N/A | 1,375 | 1,650 |
| Other Financing Activity | 1 | 1 | 1 | 14 | 14 |
| Financing Cash Flow | $270 | $270 | $1 | $1,389 | $1,664 |
| Beginning Cash Position | 862 | 862 | 862 | 91 | 91 |
| End Cash Position | 493 | 1,038 | 1,210 | 862 | 615 |
| Net Cash Flow | $-369 | $176 | $348 | $771 | $524 |
| Free Cash Flow | |||||
| Operating Cash Flow | -639 | -94 | 347 | -618 | -1,140 |
| Free Cash Flow | -639 | -94 | 347 | -618 | -1,140 |